“PD-L1 Expression As a Predictor of Response to Neoadjuvant Immunotherapy in Triple-Negative Breast Cancer”. Journal of Evidence-Based Medical Research, vol. 2, no. 03, Sept. 2026, pp. 58-69, https://doi.org/10.66687/jebmr.2.03.2026.43.